GB Sciences, Inc.
GBLX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 56.13% | -4.36% | 83.70% | 58.27% | -38.68% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -27.70% | 6.16% |
| Total Other Non-Cash Items | -- | -- | -100.00% | -2,076.74% | -343.08% |
| Change in Net Operating Assets | 274.66% | 139.31% | -16.30% | 517.58% | 106.43% |
| Cash from Operations | 73.89% | 79.11% | -14.82% | 48.57% | 32.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 6,638.46% | 875.58% |
| Cash from Investing | -- | -- | -- | 6,638.46% | 875.58% |
| Total Debt Issued | 120.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | 11.00% | -85.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 271.15% | 100.00% | 91.42% |
| Cash from Financing | -56.42% | -60.00% | 342.65% | 95.88% | -79.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.93% | 85.06% | 96.65% | 77.30% | -87.60% |